tributyrin has been researched along with Acute Liver Injury, Drug-Induced in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Barve, S; Donde, H; Ghare, S; Gobejishvili, L; Joshi-Barve, S; Lorkiewicz, P; McClain, CJ; Srivastava, S; Vadhanam, MV; Zhang, J | 1 |
Aoyama, M; Iizuka, N; Miyoshi, M; Sakaki, H; Shuno, K; Usami, M; Usami, Y | 1 |
2 other study(ies) available for tributyrin and Acute Liver Injury, Drug-Induced
Article | Year |
---|---|
Tributyrin Inhibits Ethanol-Induced Epigenetic Repression of CPT-1A and Attenuates Hepatic Steatosis and Injury.
Topics: Acetylation; Administration, Oral; Animals; Carnitine O-Palmitoyltransferase; Cells, Cultured; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Down-Regulation; Drug Evaluation, Preclinical; Epigenetic Repression; Ethanol; Fatty Liver, Alcoholic; Hepatocytes; Histone Deacetylase Inhibitors; Histones; Humans; Liver; Liver Function Tests; Male; Mice; Primary Cell Culture; Promoter Regions, Genetic; Triglycerides | 2020 |
Oral administration of tributyrin increases concentration of butyrate in the portal vein and prevents lipopolysaccharide-induced liver injury in rats.
Topics: Administration, Oral; Animals; Blotting, Western; Butyrates; Chemical and Drug Induced Liver Injury; Lipopolysaccharides; Liver; Male; NF-kappa B; Portal Vein; Rats; Rats, Wistar; RNA, Messenger; Toll-Like Receptor 2; Toll-Like Receptor 4; Triglycerides; Tumor Necrosis Factor-alpha; Upper Gastrointestinal Tract | 2011 |